Delivery Order SPE2DB20D3303-SPE2DB25FA1SS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,460.56 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract, awarded on July 22, 2025, with completion targeted for July 23, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a $7,691.02 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $11,472.94 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Jardiance 25 mg tablets, a diabetes medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform the delivery from its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major...
- The Defense Logistics Agency awarded a $5,669.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication, with an ultimate completion date of July 25, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $14,395.43 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, an oral diabetes medication. The contract was competitively awarded on July 21, 2025, with a completion date of July 22, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $35,131.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a direct supply of the diabetes medication to support federal medical procurement needs. The contract was competitively awarded with no set-aside designation, and performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,315.98 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Jardiance 25 mg tablets, a diabetes medication. This competitively awarded, firm fixed-price contract is classified as a delivery order under a larger indefinite delivery vehicle rather than a standalone agreement. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and the pharmaceuticals will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,128.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1SSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,035.72 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's position as a critical federal medical procurement vendor reflects its demonstrated capability to fulfill competitive federal requirements across the pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/24/25 |